Hologic Inc (HOLX)

Debt-to-capital ratio

Sep 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019
Long-term debt US$ in thousands 2,497,100 2,514,100 2,522,700 2,531,200 2,789,300 2,797,700 2,806,200 2,808,400 2,814,600 2,813,400 2,819,600 2,712,200 2,654,700 2,672,100 2,689,500 2,713,900 2,731,300 2,749,300 2,769,400 2,783,600
Total stockholders’ equity US$ in thousands 5,130,000 4,844,400 4,653,800 5,016,900 5,182,000 5,300,800 5,092,500 4,876,200 4,997,900 4,792,700 4,519,100 4,218,600 3,877,100 3,794,400 3,267,900 2,705,200 2,255,100 2,086,100 2,250,800 2,115,700
Debt-to-capital ratio 0.33 0.34 0.35 0.34 0.35 0.35 0.36 0.37 0.36 0.37 0.38 0.39 0.41 0.41 0.45 0.50 0.55 0.57 0.55 0.57

September 30, 2024 calculation

Debt-to-capital ratio = Long-term debt ÷ (Long-term debt + Total stockholders’ equity)
= $2,497,100K ÷ ($2,497,100K + $5,130,000K)
= 0.33

The debt-to-capital ratio of Hologic Inc has shown a relatively stable trend over the past 2 years, hovering around the range of 0.33 to 0.57. The ratio measures the proportion of total debt to total capital employed by the company, indicating its reliance on debt financing versus equity.

From December 2021 to September 2024, there has been a gradual increase in the debt-to-capital ratio, starting at 0.38 and reaching 0.33 as of September 2024. This downward trend suggests that the company has been reducing its debt levels in relation to its overall capital base.

A lower debt-to-capital ratio indicates a lower dependence on debt for financing operations, potentially signaling a stronger financial position and lower financial risk for the company. However, it is important to consider the industry norms and peer comparisons to accurately assess Hologic Inc's leverage position in the market.


Peer comparison

Sep 30, 2024

Company name
Symbol
Debt-to-capital ratio
Hologic Inc
HOLX
0.33
GE HealthCare Technologies Inc.
GEHC
0.54